Tandem Diabetes Care (NSDQ:TNDM) last week launched its t:slim X2 insulin pump with Basal-IQ technology in the U.S.
The company’s latest pump includes a predictive low glucose suspend feature designed to reduce the frequency and duration of hypoglycemia.
Using the Basal-IQ algorithm, the system predicts where a user’s blood sugar levels are heading up to 30 minutes into the future. When the algorithm predicts low glucose levels, the device suspends insulin delivery and automatically resumes once glucose levels begin to rise, according to Tandem.
